A61P 43 - Drugs for specific purposes, not provided for in groups

Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
10/1994
10/13/1994	WO1994022814A1 Cycloalkylhydroxyureas and their use as lipoxygenase inhibitors
10/13/1994	WO1994022809A1 Substituted (arylalkylaminobenzyl)aminopropionamide derivatives, their preparation and use anti-epileptic, neuroprotective and antidepressant agents
10/13/1994	WO1994022807A1 Urea and amide derivatives and their use in the control of cell membrane potassium channels
10/13/1994	WO1994022483A2 Prodrugs with enhanced penetration into cells
10/13/1994	WO1994022468A1 Method for delivering beneficial compositions to hair follicles
10/13/1994	WO1994022464A1 Urokinase plasminogen activator fragments
10/13/1994	WO1994022463A1 Oesteoblast growth stimulating compostion containing pdgf and vitamin d
10/13/1994	WO1994022457A1 Method and composition for treatment of osteoporosis
10/13/1994	WO1994022455A1 Methods of affecting the growth of living tissue in mammals and compounds and compositions therefor
10/13/1994	WO1994022437A2 Method for treating amyloidosis
10/13/1994	WO1994022433A1 Broiler ascites preventive and method of preventing ascites
10/13/1994	WO1994022427A1 Method for preparing drugs to treat dermal disorders
10/13/1994	WO1994022425A1 Anti-oxidant alkylaryl polyether alcohol polymers
10/13/1994	WO1994022312A1 Method and composition for treatment of osteoporosis
10/13/1994	WO1994022309A1 Synthetic matrix metalloprotease inhibitors and uses thereof
10/13/1994	WO1994020459A3 Pyrrolo-pyridine derivatives as dopamine receptor ligands
10/13/1994	WO1994012635A3 Novel seven transmembrane receptors
10/13/1994	CA2160139A1 Synthetic matrix metalloprotease inhibitors and uses thereof
10/13/1994	CA2160135A1 Method for screening for receptor agonists
10/13/1994	CA2159717A1 Methods of affecting the growth of living tissue in mammals and compounds and compositions therefor
10/13/1994	CA2159637A1 Urokinase plasminogen activator fragments
10/13/1994	CA2159506A1 Inhibitor of stem cell proliferation and uses thereof
10/13/1994	CA2159499A1 Biologically active polypeptide fusion dimers
10/13/1994	CA2159498A1 Method for preparing drugs to treat dermal disorders
10/13/1994	CA2159354A1 Method and composition for treatment of osteoporosis
10/13/1994	CA2158663A1 Perhydroisoindole derivatives, their preparation and pharmaceutical compositions containing them
10/13/1994	CA2156262A1 Furo¬3,2-b\|pyridines and thieno¬3,2-b\|pyridines as inhibitors of leukotriene biosynthesis
10/13/1994	CA2155307A1 Heterocyclic compounds as platelet aggregation inhibitors
10/13/1994	CA2136743A1 Benzothiazole compound, production thereof and use thereof
10/13/1994	CA2135912A1 A retroviral vector capable of transducing the aldehyde dehydrogenase-1 gene and uses of said vector
10/12/1994	EP0619306A1 19-Nor-vitamin D3 compounds with substituent at 2-position
10/12/1994	EP0619305A1 Lactone compound and process of producing thereof
10/12/1994	EP0619296A1 Phenylalkan(en)oic acids with leukotriene B4 antagonistic activity
10/12/1994	EP0619117A2 Use of acemannan
10/12/1994	EP0619115A1 Container comprising a metered dose valve and microparticles of a drug for topical treatment of skin disorders
10/12/1994	EP0618967A1 Ifn-gamma antagonist cytokine
10/12/1994	EP0618927A1 Cytokines with an unpaired cysteine residue and conjugates thereof
10/12/1994	EP0618925A1 Gapped 2' modified oligonucleotides
10/12/1994	EP0618898A1 Amidino derivatives and their use as nitric oxide synthase inhibitors
10/12/1994	EP0618889A1 Tri-substituted phenyl derivatives and processes for their preparation
10/12/1994	EP0618811A1 Proteolytic mixture containing escharase and method of isolating same
10/12/1994	EP0618805A1 Methods for the treatment of osteoporosis using bisphosphonates and parathyroid hormone
10/12/1994	EP0618802A1 Synthetic compounds and compositions with enhanced cell binding
10/12/1994	EP0552158B1 Derivatives of aspartic acid and glutamic acid having anti-cholecystokinin activity
10/12/1994	EP0471011B1 HUMAN LACTOFERRIN cDNA SEQUENCE
10/12/1994	CN1093357A Novel selective aromatase inhibiting compounds
10/11/1994	US5354860 Process for making pure S-timolol hemihydrate
10/11/1994	US5354843 Bone disorders; antiarthritic agents; medical diagnosis of thyroid cancer; automatic solid phase synthesis; resin peptides
10/11/1994	US5354773 Use of bafilomycine and derivatives to treat bone diseases
10/11/1994	US5354769 Benzofuranylimidazole derivatives and therapeutical compositions containing the same
10/11/1994	US5354766 2-Ethoxy-1-((2'(2,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl) biphenyl-4-yl)methyl)benzimidazole-7-carboxylic acid; hypotensive agents; CNS activity
10/11/1994	US5354757 Azanoradamantanes
10/11/1994	US5354749 For treating arterial hypertension and atheroschlerosis
10/11/1994	US5354736 Synthetic compounds and compositions with enhanced cell binding
10/11/1994	CA1332411C Benzodiazepine analogs
10/11/1994	CA1332410C Benzodiazepine analogs
10/11/1994	CA1332353C Pharmaceutical composition for the treatment of skin wounds
10/11/1994	CA1332351C Method for preventing tissue damage after an ischemic episode
10/06/1994	DE4314976C1 Transdermal therapeutic systems for the administration of drugs, process for their production and their use
10/05/1994	EP0618227A1 Biologically active polypeptide fusion dimers
10/05/1994	EP0618225A1 Linear adhesion inhibitors
10/05/1994	EP0618224A1 Phosphonomethyldipeptides
10/05/1994	EP0618221A2 Heterocyclic inhibitors of farnesyl protein transferase
10/05/1994	EP0618220A1 Method for purifying interleukin-4
10/05/1994	EP0618207A1 Substituted pyridopyrimidines as antihypertensives
10/05/1994	EP0618203A1 3-O-acylated catechins and method of producing same
10/05/1994	EP0618201A1 Thiadiazinones and their use in the treatment of cardiovascular or asthmatic conditions
10/05/1994	EP0618197A1 Synthesis of CIS-decahydroisoquinoline-3-carboxylic acids
10/05/1994	EP0618193A1 Nitrogen containing bicyclic derivatives as prolyl-endopeptidase inhibitors
10/05/1994	EP0617958A1 Pharmaceutical composition having anti-alcohol, radioprotecting and anti-choleraic activity and stimulating energy metabolism, stomach mucous membrane acid-generation and secretion functions
10/05/1994	EP0617957A1 Oral formulations of ubidecarenone in form of capsules
10/05/1994	EP0617705A1 Non-peptidic surrogates of the arg-gly-asp sequence and pharmaceutical compositions comprising them.
10/05/1994	EP0617620A1 Use of 5-ht4 modulators for the manufacture of a medicament for the treatment of the bladder diseases
10/05/1994	EP0617618A1 Aryl-triflates and related compounds
10/05/1994	EP0617617A1 Compositions containing histamine-h2-receptor antagonists at low dosage
10/05/1994	EP0617616A1 Potentiation of nmda antagonists
10/05/1994	EP0617614A1 Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor
10/05/1994	EP0533695B1 IMIDAZO (4,5-c) PYRIDINES WITH PAF ANTAGONIST ACTIVITY
10/05/1994	EP0520016B1 Derivatives of urea, their preparation and medicaments containing them
10/05/1994	CN1093087A Serotoninergic ergoline derivatives
10/05/1994	CN1093084A Rhenium and technetium complexes containing a hypoxia-localizing moiety
10/05/1994	CN1092980A Crystalline amifostine compositions and mthods for the preparation and use of same
10/05/1994	CN1026064C Preparation of active oxygen inhibiting composition
10/04/1994	US5352815 Agent for suppression and interception of mailard reaction
10/04/1994	US5352784 Fused cycloalkylimidazopyridines
10/04/1994	US5352779 N-linked oligosaccharide chain of glycoprotein coded by DNA molecule eliminated from amino acid position 52 and/or 78 of the alpha subunit
10/04/1994	US5352708 Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
10/04/1994	US5352705 Dipeptide-based amide compounds; anticarcinogenic agents
10/04/1994	US5352700 Using gammalinolenic acid or other fatty acids with 18-20 carbon atoms; topical application
10/04/1994	US5352694 Pharmaceutical agents
10/04/1994	US5352690 For asthma, allergies
10/04/1994	US5352687 Substituted phenylacetamides
10/04/1994	US5352669 Increases host responsiveness to anti-neoplastic alkylating agents including chloroethylating agents for chemotheraputical treatment
10/04/1994	US5352667 Non-peptidic surrogates of the Arg-Gly-Asp sequence and pharmaceutical compositions comprising them
10/04/1994	US5352664 Thrombin derived polypeptides; compositions and methods for use
10/04/1994	US5352587 Genetic engineering
10/04/1994	US5352440 Methods for increasing melanin content in melanocytes using diacylglycerols and uses thereof
10/04/1994	US5352438 Anti-free radical topical composition based on dismutase superoxide and a phosphonic derivative
10/04/1994	CA1332223C Bone resorption
10/03/1994	CA2118985A1 Heterocyclic inhibitors of farnesyl protein transferase

1 ... 1420 1421 1422 1423 1424 1425 1426 1427 1428 1429 1430 1431 1432 1433 1434 1435 1436 1437 1438 1439 1440 ... 1564